These findings reveal that miRNA-148a exerts strong anti-inflammatory activities and is an indirect tumor suppressor that modulates colitis and colitis-associated tumorigenesis by suppressing the expression of signaling by NF-κB and STAT3 and their pro-inflammatory consequences. The gene discussed is NFKB1; the disease is colitis.